Relative Bioavailability of Phase II and Phase III Formulations of AZD0530

Mise à jour : Il y a 4 ans
Référence : NCT00771979

Femme et Homme

Extrait

The aim of the study is to compare how different formulations of AZD0530 are absorbed by the body. As for all clinical trials, safety and tolerability of the drug will be evaluated.


Critère d'inclusion

  • Healthy

Liens